FDA grants Keryx's KRX-0401 fast track designation for refractory advanced colorectal cancer April 7, 2010
U.K.'s National Health Service recommends approval of Lilly's Alimta for advanced nonsquamous NSCLC April 7, 2010
Safety board recommends continuation of Celsion's phase I/II ThermoDox trial in breast cancer April 7, 2010
RSS